https://www.selleckchem.com/pr....oducts/sabutoclax.ht
However, the optimal practice for follow-up remains unclear and there is an active search for imaging markers for recurrent disease, including CT texture analysis, biomarker assays, new PET/CT isotopes, and magnetic resonance imaging. The aim of the study was to review the radiological changes that are objectified after pulmonary SBRT and the metabolic changes in F-FDG PET/CT, to assess the usefulness of following up patients with F-FDG PET/CT. At present, the evaluation of response and diagnosis of relapse after SBRT are difficult a